Anticipated Release Date: TBD Chemical indicators; Low-cost, easy to use, ultra-low SWaP modular open system based chemical detector that is widely distributed to the General Forces as an integrated kit for indication of chemical hazards; Read More
Anticipated Release Date: Q4 FY27 Host response based test to predict illness severity. Responding to this opportunity requires membership in the Medical CBRN Defense Consortium (MCDC). This Consortium releases numerous solicitations throughout the year, so even Read More
Anticipated Release Date: TBD FFBS Increment 2 will focus on automating the sample preparation process and meeting any key performance parameter thresholds that were not met during the development of FFBS Increment 1. This is Read More
Due: March 9, 2026 The Department of Health and Human Services (HHS) Defense Production Act (DPA) Title III Program is interested in submissions that strengthen the Nation’s security of supply for at least one (1) Read More
Due: April 7, 2026 Building on its long-standing commitment to improve lives and communities, the Elevance Health Foundation recently launched a new initiative: Community Action Leadership. This initiative brings together external thought leaders from across Read More
Due: April 3, 2026 Nearly half of all pregnancies in the United States are unintended. There is a critical need for fertility regulation methods that fit the needs of women and men throughout their reproductive Read More
Due: March 25, 2026 The Deployed Warfighter Protection (DWFP) Program’s mission is to protect deployed military personnel from arthropod vectors of medically relevant disease pathogens, including (but not limited to) arthropod disease vectors of tick-borne Read More
Due: March 13, 2026 The HIV Vaccine Research and Design (HIVRAD) Program supports projects that address hypotheses crucial to the design of an efficacious HIV/AIDS prophylactic vaccine. An application submitted in response to this Notice Read More
Due: March 10, 2026 This notice of funding opportunity (NOFO) invites applications to investigate protective and pathogenic mechanisms at the nexus of mitochondrial function and aging in the context of HIV infection, ART and exposure Read More
Due: March 8, 2026 This Notice of Funding Opportunity (NOFO) invites applications for studies of type 1 diabetes etiology and pathogenesis using data and samples from clinical trials and studies. This opportunity is intended to Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2026 - All rights reserved.